BioNexus Gene Lab (BGLC) Competitors $5.13 -0.03 (-0.58%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BGLC vs. BMGL, MRAI, MGRX, CCM, BRTX, KDLY, ACON, NIVF, DHAC, and BACKShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Basel Medical Group (BMGL), Marpai (MRAI), Mangoceuticals (MGRX), Concord Medical Services (CCM), Biorestorative Therapies (BRTX), Kindly MD (KDLY), Aclarion (ACON), NewGenIvf Group (NIVF), Digital Health Acquisition (DHAC), and IMAC (BACK). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Its Competitors Basel Medical Group Marpai Mangoceuticals Concord Medical Services Biorestorative Therapies Kindly MD Aclarion NewGenIvf Group Digital Health Acquisition IMAC Basel Medical Group (NASDAQ:BMGL) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation. Do insiders & institutionals believe in BMGL or BGLC? 18.9% of BioNexus Gene Lab shares are held by institutional investors. 0.7% of BioNexus Gene Lab shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has preferable earnings and valuation, BMGL or BGLC? Basel Medical Group has higher earnings, but lower revenue than BioNexus Gene Lab. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical GroupN/AN/AN/AN/AN/ABioNexus Gene Lab$9.51M0.97-$1.60MN/AN/A Is BMGL or BGLC more profitable? Basel Medical Group has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -30.70%. Basel Medical Group's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A BioNexus Gene Lab -30.70%-35.54%-29.08% Does the media favor BMGL or BGLC? In the previous week, Basel Medical Group and Basel Medical Group both had 1 articles in the media. BioNexus Gene Lab's average media sentiment score of 1.45 beat Basel Medical Group's score of 1.29 indicating that BioNexus Gene Lab is being referred to more favorably in the news media. Company Overall Sentiment Basel Medical Group Positive BioNexus Gene Lab Positive Do analysts rate BMGL or BGLC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00BioNexus Gene Lab 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryBioNexus Gene Lab beats Basel Medical Group on 4 of the 7 factors compared between the two stocks. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGLC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.23M$8.21B$6.09B$10.54BDividend YieldN/A2.14%5.73%4.78%P/E RatioN/A73.2484.6327.10Price / Sales0.9738.42606.05131.34Price / CashN/A21.7637.8662.13Price / Book1.116.8312.246.58Net Income-$1.60M$247.60M$3.32B$276.75M7 Day Performance-1.16%-0.34%0.76%0.91%1 Month Performance-10.00%-2.82%8.03%4.18%1 Year Performance36.26%6.36%71.13%35.42% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab0.7857 of 5 stars$5.13-0.6%N/A+34.0%$9.23M$9.51M0.0030Short Interest ↓BMGLBasel Medical GroupN/A$1.51-3.2%N/AN/A$28.79MN/A0.0036MRAIMarpaiN/A$1.55-4.3%N/A+140.5%$28.38M$34.87M-0.59150Gap UpMGRXMangoceuticals1.7456 of 5 stars$2.41-6.2%N/AN/A$27.08M$620K-0.623CCMConcord Medical Services0.5101 of 5 stars$5.57-2.4%N/A-30.4%$24.75M$52.60M0.00970Short Interest ↑High Trading VolumeBRTXBiorestorative Therapies1.5931 of 5 stars$1.62+5.9%N/A-8.7%$12.21M$400K-1.287KDLYKindly MDN/A$1.03-8.8%N/A-33.3%$6.20M$2.47M-1.34N/AHigh Trading VolumeACONAclarion2.454 of 5 stars$7.89+3.1%$11,758.50+148,930.4%-99.4%$4.46M$50K0.007Gap UpHigh Trading VolumeNIVFNewGenIvf GroupN/A$1.79+2.3%N/A-99.8%$3.77M$5.43M0.00N/ADHACDigital Health AcquisitionN/A$0.64+3.1%N/A-46.8%$2.30MN/A0.002,021BACKIMACN/A$0.08+7.1%N/A-93.8%$155K$72.05K0.00180Gap Down Related Companies and Tools Related Companies BMGL Alternatives MRAI Alternatives MGRX Alternatives CCM Alternatives BRTX Alternatives KDLY Alternatives ACON Alternatives NIVF Alternatives DHAC Alternatives BACK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGLC) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
